Author
@MacGillivrayCPA MacGillivrayCPA
grade Cx.com/MacGillivrayCPA ↗
Right-leaning CPA-trader posting punchy AI/crypto theses, doom-macro takes, and ENHA hype
Reactive financial commentary and trade recaps blending them
trader score
+1.23
hit rate
50%
mean α
+1.01%
signals 14d
56
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 50% hit rate, +1.01% mean alpha, trader score +1.23. Their last-14d mentions, direction-adjusted, have moved -2.4% since posting (mean over 37 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-07-03 | ENHA | @MacGillivrayCPA | +0.45 | Peptide market TAM and FDA compounding discussion framed as share opportunity for HIMS and ENHA. | — | tweet ↗ |
| 2026-07-03 | HIMS | @MacGillivrayCPA | +0.45 | Peptide market TAM and FDA compounding discussion framed as share opportunity for HIMS and ENHA. | — | tweet ↗ |
| 2026-07-02 | ENHA | @MacGillivrayCPA | +0.15 | Author will attend July 23 FDA meeting on recategorization of peptides; relevant peptide-exposed tickers listed. | — | tweet ↗ |
| 2026-07-02 | PPGN | @MacGillivrayCPA | +0.15 | Author will attend July 23 FDA meeting on recategorization of peptides; relevant peptide-exposed tickers listed. | · | tweet ↗ |
| 2026-07-02 | HIMS | @MacGillivrayCPA | +0.15 | Author will attend July 23 FDA meeting on recategorization of peptides; relevant peptide-exposed tickers listed. | — | tweet ↗ |
| 2026-07-02 | BANB | @MacGillivrayCPA | +0.15 | Author will attend July 23 FDA meeting on recategorization of peptides; relevant peptide-exposed tickers listed. | · | tweet ↗ |
| 2026-07-02 | LFMD | @MacGillivrayCPA | +0.15 | Author will attend July 23 FDA meeting on recategorization of peptides; relevant peptide-exposed tickers listed. | · | tweet ↗ |
| 2026-07-02 | ENHA | @MacGillivrayCPA | +0.50 | Positive expectation for Enhanced Games event and ENHA protocol visibility. | — | tweet ↗ |
| 2026-07-02 | MU | @MacGillivrayCPA | +0.25 | Says Apple may be forced to deal with Micron despite seeking Chinese alternatives. | — | tweet ↗ |
| 2026-07-02 | AAPL | @MacGillivrayCPA | -0.20 | Says Apple may be forced to deal with Micron despite seeking Chinese alternatives. | — | tweet ↗ |
| 2026-07-01 | SHAZ | @MacGillivrayCPA | -0.65 | Calls SHAZ gambling and hopium after volatile move from 80 to 90+ then 79. | -14.2% | tweet ↗ |
| 2026-07-01 | ENHA | @MacGillivrayCPA | +0.45 | FDA PCAC July 23-24 vote could move peptides from banned to permitted compounding, benefiting ENHA and HIMS. | -6.6% | tweet ↗ |
| 2026-07-01 | HIMS | @MacGillivrayCPA | +0.45 | FDA PCAC July 23-24 vote could move peptides from banned to permitted compounding, benefiting ENHA and HIMS. | -2.0% | tweet ↗ |
| 2026-06-30 | NVDA | @MacGillivrayCPA | +0.45 | Challenges Michael Burry on NVDA and TSLA, implying bullish opposition to his shorts. | -2.6% | tweet ↗ |
| 2026-06-30 | TSLA | @MacGillivrayCPA | +0.45 | Challenges Michael Burry on NVDA and TSLA, implying bullish opposition to his shorts. | -6.5% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.